| Recruiting | A Mass Balance Study of [14C] MT1013 in Hemodialysis Subjects With Secondary Hyperparathyroidism Hemodialysis Subjects With Secondary Hyperparathyroidism | Phase 1 | 2025-11-30 |
| Recruiting | A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke Acute Ischemic Stroke | Phase 2 | 2025-10-01 |
| Recruiting | Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism Secondary Hyperparathyroidism, Chronic Kidney Disease | Phase 3 | 2025-09-30 |
| Recruiting | Phase I Study of MT1011 Injection in Healthy Subjects Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation | Phase 1 | 2025-06-25 |
| Completed | MT1013 Injection for the Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis | Phase 2 | 2024-11-04 |
| Recruiting | Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidn Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis | Phase 2 | 2024-06-07 |
| Recruiting | A Clinical Study of MT1002 in Subjects With Acute Coronary Syndrome Undergoing PCI Acute Coronary Syndrome | Phase 2 | 2024-02-27 |
| Completed | A SAD/MAD Study to Evaluate the Safety, Tolerability, PK of MT200605 in Healthy Subjects Healthy | Phase 1 | 2023-07-11 |
| Completed | A Clinical Study Evaluating the Safety, Tolerability, and Efficacy of MT1013 in Hemodialysis Subjects With Sec Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis | Phase 2 | 2023-04-07 |
| Terminated | Evaluate the Effects of Renal Impairment on the Pharmacokinetics and Pharmacodynamics ACS - Acute Coronary Syndrome | Phase 1 | 2022-04-15 |
| Completed | MT1013 Clinical TRIAL In Healthy Subject Healthy Volunteer | Phase 1 | 2021-06-28 |
| Terminated | MT1002 Phase II Study in ACS Patients With PCI Acute Coronary Syndrome | Phase 2 | 2020-12-02 |
| Completed | Single Ascending Dose Trial to Evaluate the Safety, Tolerability, PK, and PD of MT1002 for Injection Healthy | Phase 1 | 2019-04-29 |